Akums Drugs & Pharma Share Price Today | Stock Price & Akums Drugs & Pharma Share Screener

Track the current stock price of Akums Drugs & Pharma with an interactive chart. Analyse AKUMS share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Akums Drugs & Pharma stock quote in one place.

The quote of ₹801.35 sits between the 52-week low of ₹414.05 and the 52-week high of ₹823.30, and the latest session moved -1.45% from the previous close.

Screen Akums Drugs & Pharma company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for AKUMS shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Pharmaceuticals industry, and it trades under ISIN INE09XN01023.

Akums Drugs and Pharmaceuticals Limited is an Indian pharmaceutical contract development and manufacturing organization (CDMO) established in 2004. The company offers a wide range of pharmaceutical products and services both domestically and internationally. Their operations include manufacturing of Active Pharmaceutical Ingredients (APIs), sale of branded pharmaceutical formulations, formulation research and...more

Classification

Identifiers and Leadership

Screen AKUMS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹5,447, up from ₹4,113 in 2025.

Latest statistics put total assets at ₹5,447 and shareholder funds at ₹3,331, with a leverage ratio of 0.04.

Screen Akums Drugs & Pharma income statement and profit fundamentals. Analyze AKUMS quarterly results. Akums Drugs & Pharma reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For 2026-Jun, revenue was ₹1,197 and net profit was ₹101, equal to earnings per unit of ₹6.53, at an operating margin of 15%.

In that period expenses were ₹992, interest cost ₹25 and tax ₹38. The next period listed, 2026-Mar, shows revenue of ₹1,193 and net profit of ₹81.

Screen AKUMS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹1,181, and net cash flow was an inflow of ₹285.

Over the same period, investing activities used ₹930 and financing activities provided ₹34.

See Akums Drugs & Pharma shareholding pattern with promoter, FII, and DII holdings. Check Akums Drugs & Pharma promoter holding and ownership changes for AKUMS on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Jun, promoters held 75.26%, foreign institutions 1.91%, domestic institutions 13.44% and the public 5.57%, spread across 70,289 shareholders.

The shareholder count was 70,289 in 2026-Jun, compared with 72,589 in 2026-Mar.

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Akums Drugs & Pharma. Akums Drugs & Pharma dividend yield can be compared with peers and other stocks in the market.

The latest dividend recorded was ₹3.00 per unit for 2026-March, a yield of 0.38%, compared with ₹0.00 for 2025-March.

Dividends are listed for 10 periods, with the three most recent payouts at ₹3.00, ₹0.00 and ₹0.00 per unit.

See which indices include Akums Drugs & Pharma stock. Check AKUMS index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

The company is listed in 11 indices, including BSE INDEX BSE HC.

Among the benchmarks tracked are BSE INDEX BSE HC, BSE INDEX BSEIPO, BSE INDEX SMLCAP, NIFTY 500.

Get Akums Drugs & Pharma corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Akums Drugs & Pharma stock events that may affect AKUMS share price, along with derivatives, futures and options activity and sector gainers.

12 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated August 8, 2026, with a record date of August 8, 2026.

It is followed by Annual General Meeting dated July 10, 2026 and Dividend dated July 3, 2026.

Screen AKUMS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Screen AKUMS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated October 2, 2026.

The next most recent announcements are dated September 30, 2026 and September 16, 2026.

Quotes are sourced from the NSE and the BSE. Key statistics were last updated on October 6, 2026. This page covers 7 balance sheet periods, 13 income statement periods, 9 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.